We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+0.07%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$740M
AUM Growth
-$26.6M
Cap. Flow
-$11.6M
Cap. Flow %
-1.57%
Top 10 Hldgs %
45.11%
Holding
310
New
89
Increased
45
Reduced
51
Closed
109

Sector Composition

Rank Sector Weight
1 Healthcare 33.59%
2 Financials 26.36%
3 Technology 13.34%
4 Industrials 9.39%
5 Materials 6.61%

Similar funds

Crestline Management's Q3 2022 Portfolio in Review

As of Q3 2022, Crestline Management held 310 positions worth $740M, down 3.5% from $766M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Crestline Management's Q3 2022 filing shows 89 new, 45 increased, 51 reduced and 109 closed positions. Its largest new stake was US Bancorp: 345,000 shares worth $13.9M. The largest sale was Bank of America, an estimated $9.96M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Financials and Technology.

  • Crestline Management's largest Q3 2022 buy was US Bancorp: 345,000 shares worth $13.9M.
  • Crestline Management added most to NCR Voyix in Q3 2022, an estimated $6.86M increase.
  • Crestline Management's biggest Q3 2022 reduction was Denali Therapeutics, cutting an estimated $9.75M.
  • Crestline Management fully exited Bank of America in Q3 2022, selling an estimated $9.96M.
  • Crestline Management's ten largest holdings make up 45% of its $740M portfolio in Q3 2022.
  • Crestline Management opened 89 new positions and closed 109 in Q3 2022.
  • Crestline Management's portfolio value fell 3.5% quarter-over-quarter to $740M.

Based on Crestline Management's 13F filing for Q3 2022, filed 14 Nov 2022.